. Author manuscript; available in PMC: 2019 Nov 22.

Published in final edited form as: Int J Tuberc Lung Dis. 2019 Jan 1;23(1):82–92. doi: 10.5588/ijtld.18.0203

Table 6.

Characteristics of studies included in the meta-analysis

Author, country, reference	Year	Smear results	Xpert results	RR (95%CI)
Author, country, reference	Year	Unfavorable^† n/N (%)	Unfavorable n/N (%)^‡	RR (95%CI)
Fielding, South Africa¹⁶	2015	31/249 (12)	25/231 (11)	1.05 (0.70–1.59)
Agizew, Botswana¹⁵	2015	8/39 (21)	32/162 (20)	1.04 (0.52–2.07)
Trajman, Brazil¹⁴	2015	409/1676 (24)	444/2015 (22)	1.12 (0.98–1.23)
Cox, South Africa¹³	2014	28/204 (14)	34/249 (14)	1.00 (0.63–1.56)

TB patients who initiated treatment with known treatment outcome smear group.

^†

Treatment failure, death, loss to follow-up.

^‡

TB patients initiated treatment with known treatment outcome Xpert group.

RR = risk ratio; CI = confidence interval.